Sentence examples for genome testing for from inspiring English sources
Now we can perform powerful genetic analyses while also completely protecting our participants' privacy". Previously: Locking the door on big-data risks to privacy, Genome testing for children: What parents should consider and Stanford patient on having her genome sequenced: "This is the right thing to do for our family".
Yes my natural response to most things of this kind is caution but I recall about 10 years ago there was a genetics white paper from the Department of Health which suggested full genome testing for all new born babies.
Personal genome testing for multifactorial diseases is conducted on the basis of genetic profiling.
Current personal genome testing for multifactorial diseases is not likely to pass the test in either perspective.
A third main ELSI associated with personal genome testing for multifactorial diseases is the legal and societal issue of regulation.
Thus, consideration of test characteristics is indispensible to any valuable ELSI-debate on personal genome testing for multifactorial diseases.
On Friday, 23andMe, the company that allows consumers to get portions of their genome tested for a relatively modest fee, announced that "a number of new 23andMe customer samples were incorrectly processed" by the lab 23andMe contracts" to carry out its tests.
The Boston-based company Veritas Genetics sells entire genome tests for newborns in China for $1,900, and will begin offering the same in the United States in the next two years, said Veritas' chief marketing officer, Rodrigo Martinez.
In this section, the implications of the test characteristics of personal genome tests for the discourse on ELSI will be discussed.
As a consequence of their limited clinical validity, present-day personal genome tests for multifactorial diseases have a much lower potential for adverse psychological effects than do clinical genetic tests for monogenic diseases.
These uncertainties may pose challenges for the provision of pre- and post-test information on personal genome testing and for its informed consent processes.
